Remove Drug Development Remove Packaging Remove White Paper
article thumbnail

Lisata collaborates with GATC Health on drug development

Pharmaceutical Technology

June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GATC’s MAT platform identifies potential new drugs and provides comprehensive analytic reports. Lisata Therapeutics has formed a strategic partnership with GATC Health to advance AI-driven drug discovery and development.

article thumbnail

The Important Role that Biopharmaceutics Plays in Accelerating Early-Phase Drug Development

Pharmaceutical Technology

As formulators, we are often able to directly impact the amount of drug absorbed through formulation optimization and improve exposure. However, the chances of improving the exposure profile of a drug that is highly cleared by formulation modification are limited.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

RFK Jr looks to alter rare disease regulation by fast-tracking drug approvals

Pharmaceutical Technology

wants to ensure the ensuing the US does not lag behind other countries in drug development. We want to make sure we are getting rid of the regulatory impediments [that stop drugs getting to market],” RFK Jr stated. Tasos Katopodis / Stringer via Getty Images. Give your business an edge with our leading industry insights.

article thumbnail

Actio gains $66m to advance small molecule therapeutics pipeline

Pharmaceutical Technology

Actio Biosciences CEO and co-founder David Goldstein stated: “We have made tremendous progress across our pipeline – executing a precision medicine strategy that targets the root causes of disease through genetically informed drug development. Give your business an edge with our leading industry insights.

article thumbnail

Eli Lilly and Eisai’s Alzheimer’s drugs denied NHS use due to high costs

Pharmaceutical Technology

Kisunla and Leqembi were touted as the most promising treatments to emerge from Alzheimer’s drug development in recent times. However, side effects from the drugs can be serious, and their high cost has been a barrier to reimbursement. Give your business an edge with our leading industry insights.

article thumbnail

DoH – Abu Dhabi and Sanofi link for vaccine development

Pharmaceutical Technology

Give your business an edge with our leading industry insights.

article thumbnail

Draig secures $140m for neuropsychiatric disorder therapies

Pharmaceutical Technology

Give your business an edge with our leading industry insights.